223 related articles for article (PubMed ID: 17932585)
21. Chronic inflammation: A key role in degeneration of bicuspid aortic valve.
Manno G; Bentivegna R; Morreale P; Nobile D; Santangelo A; Novo S; Novo G
J Mol Cell Cardiol; 2019 May; 130():59-64. PubMed ID: 30885747
[TBL] [Abstract][Full Text] [Related]
22. Pathology of calcific aortic stenosis.
Ladich E; Nakano M; Carter-Monroe N; Virmani R
Future Cardiol; 2011 Sep; 7(5):629-42. PubMed ID: 21929343
[TBL] [Abstract][Full Text] [Related]
23. Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.
Guddeti RR; Patil S; Ahmed A; Sharma A; Aboeata A; Lavie CJ; Alla VM
Prog Cardiovasc Dis; 2020; 63(4):496-502. PubMed ID: 32526213
[TBL] [Abstract][Full Text] [Related]
24. Prediction of degeneration of native and bioprosthetic aortic valves: issue-related particularities of diabetes mellitus.
Yeghiazaryan K; Bauriedel G; Schild HH; Golubnitschaja O
Infect Disord Drug Targets; 2008 Jun; 8(2):88-99. PubMed ID: 18537704
[TBL] [Abstract][Full Text] [Related]
25. [Research progress on pharmacotherapy of calcific aortic valve disease].
DU M; Ma G; Shi Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):432-438. PubMed ID: 27868419
[TBL] [Abstract][Full Text] [Related]
26. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention.
Parolari A; Loardi C; Mussoni L; Cavallotti L; Camera M; Biglioli P; Tremoli E; Alamanni F
Eur J Cardiothorac Surg; 2009 Mar; 35(3):493-504. PubMed ID: 19162497
[TBL] [Abstract][Full Text] [Related]
27. Morphologic findings in explanted Mitroflow pericardial bioprosthetic valves.
McGonagle-Wolff K; Schoen FJ
Am J Cardiol; 1992 Jul; 70(2):263-4. PubMed ID: 1626518
[No Abstract] [Full Text] [Related]
28. Determinants of occurrence of aortic sclerosis in an aging population.
Ngo DT; Sverdlov AL; Willoughby SR; Nightingale AK; Chirkov YY; McNeil JJ; Horowitz JD
JACC Cardiovasc Imaging; 2009 Aug; 2(8):919-27. PubMed ID: 19679278
[TBL] [Abstract][Full Text] [Related]
29. Structural valve deterioration and mode of failure of stentless bioprosthetic valves.
Della Barbera M; Pettenazzo E; Livi U; Mangino D; Gerosa G; Bottio T; Basso C; Valente M; Thiene G
Cardiovasc Pathol; 2021; 51():107301. PubMed ID: 33130282
[TBL] [Abstract][Full Text] [Related]
30. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation.
Passmore M; Nataatmadja M; Fung YL; Pearse B; Gabriel S; Tesar P; Fraser JF
Eur J Cardiothorac Surg; 2015 Sep; 48(3):e20-9. PubMed ID: 26273067
[TBL] [Abstract][Full Text] [Related]
31. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
[TBL] [Abstract][Full Text] [Related]
32. Calcific aortic valve disease: is it another face of atherosclerosis?
Sathyamurthy I; Alex S
Indian Heart J; 2015; 67(5):503-6. PubMed ID: 26432749
[TBL] [Abstract][Full Text] [Related]
33. Understanding the structural features of symptomatic calcific aortic valve stenosis: A broad-spectrum clinico-pathologic study in 236 consecutive surgical cases.
Galli D; Manuguerra R; Monaco R; Manotti L; Goldoni M; Becchi G; Carubbi C; Vignali G; Cucurachi N; Gherli T; Nicolini F; Lorusso R; Vitale M; Corradi D
Int J Cardiol; 2017 Feb; 228():364-374. PubMed ID: 27866029
[TBL] [Abstract][Full Text] [Related]
34. The lipid theory in the pathogenesis of calcific aortic stenosis.
Parisi V; Leosco D; Ferro G; Bevilacqua A; Pagano G; de Lucia C; Perrone Filardi P; Caruso A; Rengo G; Ferrara N
Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):519-25. PubMed ID: 25816732
[TBL] [Abstract][Full Text] [Related]
35. Pathology and etiology of 110 consecutively removed aortic valves.
Chuangsuwanich T; Warnnissorn M; Leksrisakul P; Laksanabunsong P; Thongcharoen P; Sahasakul Y
J Med Assoc Thai; 2004 Aug; 87(8):921-34. PubMed ID: 15471297
[TBL] [Abstract][Full Text] [Related]
36. Aortic valve sclerosis as a marker of active atherosclerosis.
Branch KR; O'Brien KD; Otto CM
Curr Cardiol Rep; 2002 Mar; 4(2):111-7. PubMed ID: 11827633
[TBL] [Abstract][Full Text] [Related]
37. HISTOLOGICAL AND IMMUNOHISTOCHEMICAL STUDIES OF ATHEROSCLEROTIC AND SENILE CALCIFIC AORTIC VALVE STENOSIS.
Saladze T; Gogiashvili L; Tsagareli Z; Bakhutashvili Z; Kavtaradze T
Georgian Med News; 2015; (244-245):94-9. PubMed ID: 26177142
[TBL] [Abstract][Full Text] [Related]
38. A metric for the stiffness of calcified aortic valves using a combined computational and experimental approach.
Maleki H; Shahriari S; Durand LG; Labrosse MR; Kadem L
Med Biol Eng Comput; 2014 Jan; 52(1):1-8. PubMed ID: 24037347
[TBL] [Abstract][Full Text] [Related]
39. Development of calcific aortic valve disease: Do we know enough for new clinical trials?
Kostyunin AE; Yuzhalin AE; Ovcharenko EA; Kutikhin AG
J Mol Cell Cardiol; 2019 Jul; 132():189-209. PubMed ID: 31136747
[TBL] [Abstract][Full Text] [Related]
40. Interstitial cells in calcified aortic valves have reduced differentiation potential and stem cell-like properties.
Bogdanova M; Zabirnyk A; Malashicheva A; Enayati KZ; Karlsen TA; Kaljusto ML; Kvitting JP; Dissen E; Sullivan GJ; Kostareva A; Stensløkken KO; Rutkovskiy A; Vaage J
Sci Rep; 2019 Sep; 9(1):12934. PubMed ID: 31506459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
